We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Blood Cholesterol Testing System Is Cheaper, More Efficient, and Faster

By LabMedica International staff writers
Posted on 08 Nov 2022

Total cholesterol contained in the body within normal limits is an important substance, without which the proper functioning of the body is impossible. More...

Elevated blood cholesterol is a symptom of a number of diseases, such as atherosclerosis, hereditary diseases, chronic kidney failure, nephroptosis, hypertension, liver disease, pancreatic diseases. Now, scientists have developed a new sensor device for determining cholesterol levels in the blood. The system does not use protein compounds, namely enzymes. Chemists replaced them with an inorganic analogue - copper chloride. This allowed to make the process of creating cholesterol meters cheaper, to make blood testing easier, faster and more accessible.

To measure cholesterol levels with the new device developed by scientists at the Ural Federal University (UrFU, Ekaterinburg, Russia), a small amount of blood is enough. The blood is placed in an analyzing chip containing a solution of copper chloride in acetonitrile. An electrode is integrated into this chip, which is connected to a voltammetric analyzer that gives the results of the analysis. The advantage of the new chip analyzing cholesterol levels is also that it contains magnetic nanoparticles with polymers with molecular imprints that selectively sorb cholesterol, screening out any other substances characteristic of blood composition.

The microfluidic chip, in which all elements of the system are integrated, is printed on a 3D printer, which also facilitates the production process of the device, making it faster. Scientists note that the first test they conducted not on biological samples, but on model solutions that mimic blood serum. The next stage of the researchers' work is to test the system on real blood samples.

"Cholesterol determination is currently performed using colorimetry, chromatography, and enzymes. However, these methods use either extremely aggressive reagents or complex and expensive equipment, or - as recognizing and sensitive elements that determine cholesterol levels - enzymes - biological molecules that are extracted from living organisms. For example, the enzyme cholesterol oxidase is produced by some species of bacteria. Also enzymes are natural polymers, proteins, therefore, they are prone to denaturation and require certain storage conditions, temperature and acidity regimes. We decided to select a non-biological analogue of this enzyme to make the process of cholesterol analysis cheaper, easier and faster. One of the most affordable options is copper chloride, which we first discovered to be highly sensitive to cholesterol," explained Andrey Okhokhonin, Associate Professor at the Ural Federal University Department of Analytical Chemistry.

"Molecular imprinted polymers are needed to effectively separate cholesterol from other substances in the blood. After trying several options, we chose ethylene glycol dimethacrylate as the crosslinking agent and vinylpyridine as the functional monomer. The polymer synthesized on the surface of magnetic nanoparticles effectively sorbs cholesterol, so we can talk about high selectivity of analysis, as no other substances interfere," emphasized Ohokhonin.

Related Links:
UrFU 


New
Gold Member
Hybrid Pipette
SWITCH
Collection and Transport System
PurSafe Plus®
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Impaired vascular function in patients with chronic kidney disease (A K Grotle et al., Am J Physiol Renal Physiol (2025). DOI: 10.1152/ajprenal.00158.2025)

Kidney Disease Blood Marker Could Also Identify Cardiovascular Problems

Chronic kidney disease (CKD) affects millions worldwide and is strongly linked to cardiovascular complications rather than kidney failure itself. Patients with CKD often experience vascular dysfunction... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The tool enables scientists to track real-time fluctuations in T cell function with unprecedented speed and precision (Photo courtesy of Shutterstock)

Luminescent Probe Measures Immune Cell Activity in Real Time

The human immune system plays a vital role in defending against disease, but its activity must be precisely monitored to ensure effective treatment in cancer therapy, autoimmune disorders, and organ transplants.... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.